I believe 2022 will see the biotech stock trade lower, barring unbelievably positive news about Covaxin, its Covid-19 vaccine. But, of course, the UK just reported its first death from the omicron …
More Ocugen Stock Finally Sunk to Penny Status, But That Doesn’t Make It a Buy Videos